Who are i.m. injection of vitamin B12's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Vitamin B12, Hydroxocobalamin Chloride Injection, B vitamin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/i-m-injection-of-vitamin-b12.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

i.m. injection of vitamin B12 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

i.m. injection of vitamin B12 (i.m. injection of vitamin B12) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin supplement / Essential nutrient. Area: Hematology / Neurology.

marketed Vitamin supplement / Essential nutrient Methionine synthase, methylmalonyl-CoA mutase Hematology / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

i.m. injection of vitamin B12 (i.m. injection of vitamin B12) — University Hospital, Basel, Switzerland. Vitamin B12 (cobalamin) acts as a cofactor for enzymes involved in DNA synthesis, myelin formation, and energy metabolism.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
i.m. injection of vitamin B12 TARGET	i.m. injection of vitamin B12	University Hospital, Basel, Switzerland	marketed	Vitamin supplement / Essential nutrient	Methionine synthase, methylmalonyl-CoA mutase
Vitamin B12	Vitamin B12	Acrotech Biopharma Inc.	marketed	Vitamin / Essential nutrient	Methionine synthase, methylmalonyl-CoA mutase
Hydroxocobalamin Chloride Injection	Hydroxocobalamin Chloride Injection	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	phase 3	Vitamin B12 (cobalamin) supplement	Cobalamin-dependent enzymes (methionine synthase, methylmalonyl-CoA mutase)
B vitamin	B vitamin	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	marketed	Vitamin supplement / Essential nutrient

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin supplement / Essential nutrient class)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS · 1 drug in this class
University Hospital, Basel, Switzerland · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). i.m. injection of vitamin B12 — Competitive Intelligence Brief. https://druglandscape.com/ci/i-m-injection-of-vitamin-b12. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab